EMD-50707

Single-particle
3.3 Å
EMD-50707
3D View Gallery
Deposition: 18/06/2024
Map released: 19/03/2025
Last modified: 02/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-50707

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9fr3 summary report (pdf.gz) Map-9fr3 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Structure of the SARS-CoV-2 spike glycoprotein in complex with nanobody 7F

EMD-50707

Single-particle
3.3 Å
EMD-50707
3D View Gallery
Deposition: 18/06/2024
Map released: 19/03/2025
Last modified: 02/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Lama glama, Severe acute respiratory syndrome coronavirus
Sample: SARS2 spike glycoprotein ectodomain in complex with the 7F nanobody
Fitted models: 9fr3

Deposition Authors: Debski-Antoniak O , Drulyte I , Hurdiss DL
A bivalent spike-targeting nanobody with anti-sarbecovirus activity.
Swart IC, Debski-Antoniak OJ, Zegar A , de Bouter T, Chatziandreou M, van den Berg M, Drulyte I , Pyrc K, de Haan CAM , Hurdiss DL , Bosch BJ, Oliveira S
(2025) J Nanobiotechnology , 23 , 196 - 196
PUBMED: 40059135
DOI: doi:10.1186/s12951-025-03243-y
ISSN: 1477-3155
Grant Support: